JuHyun Bae | Cancer immunotherapy | Best Researcher Award

Best Researcher Award

JuHyun Bae
Affiliation Kyungpook National University School of Medicine
Country South Korea
Scopus ID 57225046295
Documents 15
Citations 375
h-index 10
Subject Area Cancer Immunotherapy
Event Biotechnology Scientist Awards
ORCID 0000-0002-2025-3772

JuHyun Bae
Kyungpook National University School of Medicine

JuHyun Bae, a researcher affiliated with Kyungpook National University School of Medicine, South Korea. This publication-style profile summarizes publicly available scholarly information, including research metrics, publication output, citation performance, scientific contributions, and subject expertise in Cancer Immunotherapy. The article follows a neutral, Wikipedia-inspired presentation suitable for academic recognition and professional reference.[1]

Abstract

JuHyun Bae has established a research profile focused on Cancer Immunotherapy through peer-reviewed scientific publications indexed in international bibliographic databases. Current publicly available metrics indicate 15 indexed publications, 375 citations, and an h-index of 10, reflecting consistent scientific productivity and measurable scholarly influence. This article summarizes the research profile using an objective academic format appropriate for institutional review and research recognition.[1]

Keywords

Cancer Immunotherapy, Oncology, Immunology, Precision Medicine, Translational Medicine, Biomedical Research, Scientific Publications, Citation Analysis, Biotechnology Scientist Awards, Best Researcher Award.

Introduction

Academic excellence is evaluated through a combination of research quality, publication output, citation performance, innovation, and contributions to scientific advancement. Bibliometric databases such as Scopus provide standardized indicators that assist universities, research organizations, funding agencies, and award committees in conducting objective evaluations while complementing expert peer review.[2]

Research Profile

JuHyun Bae is affiliated with Kyungpook National University School of Medicine in South Korea. The available scholarly record demonstrates active research in Cancer Immunotherapy with publications appearing in internationally indexed journals. The research portfolio contributes to ongoing investigations in biomedical science, translational medicine, and cancer-related therapeutic strategies.[1]

Research Contributions

  • Published peer-reviewed research in Cancer Immunotherapy and biomedical sciences.
  • Supported advances in translational oncology research.
  • Contributed to internationally indexed scientific literature.
  • Participated in collaborative biomedical research activities.
  • Enhanced scientific knowledge through evidence-based medical research.

Publications

The researcher’s Scopus profile records 15 indexed publications. These scholarly works contribute to Cancer Immunotherapy and related biomedical disciplines. Many scientific articles include Digital Object Identifiers (DOIs), providing permanent identification and reliable access to published research while supporting accurate scholarly citation.[3]

  • Peer-reviewed journal publications indexed in Scopus.
  • Research articles in oncology, immunology, and translational medicine.

Research Impact

Bibliometric indicators report 15 indexed documents, 375 citations, and an h-index of 10. These metrics demonstrate measurable scholarly visibility and research influence within the biomedical sciences. Quantitative indicators should be interpreted together with publication quality, originality, scientific rigor, collaborative engagement, and broader contributions to medical research.[1]

Award Suitability

Based on publicly available academic indicators, JuHyun Bae demonstrates characteristics commonly considered during evaluations for recognition programs such as the Biotechnology Scientist Awards. Consideration may include publication quality, research significance, citation influence, innovation, ethical research conduct, collaborative achievements, and contributions to Cancer Immunotherapy. Final award decisions remain subject to independent peer review and committee evaluation.[2]

Conclusion

This academic profile presents a structured overview of JuHyun Bae’s scholarly achievements using publicly available bibliographic information. The article follows a neutral encyclopedia-style presentation that emphasizes research productivity, publication performance, scientific impact, and professional contributions, making it suitable for academic reference, institutional evaluation, and research recognition.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: JuHyun Bae, Author ID 57225046295. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57225046295
  2. Systematic discovery of immunomodulatory plant-derived nanoparticles reveals RNA-mediated macrophage reprogramming.
    https://www.sciencedirect.com/science/article/pii/S2452199X26003701?via%3Dihub
  3. Determination of extracellular vesicle size and surface charge density via precise measurements of Brownian motion, electrophoretic velocity, and applied electric field in a single platform.
    https://www.sciencedirect.com/science/article/abs/pii/S0925400526001486?via%3Dihub

Na-Eun Kim | Immunotherapy | Best Researcher Award

Best Researcher Award

Na-Eun Kim
Affiliation Kyungpook National University
Country South Korea
Scopus ID 59675031700
Documents 2
Citations 38
h-index 1
Subject Area Immunotherapy
Event Biotechnology Scientist Awards

Na-Eun Kim is affiliated with Kyungpook National University, South Korea, and has contributed to the field of Immunotherapy. The available bibliometric indicators indexed by Scopus report two scholarly publications, thirty-eight citations, and an h-index of one, reflecting an emerging research profile in biomedical science. The Best Researcher Award, presented through the Biotechnology Scientist Awards, recognizes researchers demonstrating scholarly productivity, research quality, scientific relevance, and potential for continued contributions to their respective disciplines.[1]

Abstract

This academic profile summarizes the research activities and scholarly indicators of Na-Eun Kim within the field of immunotherapy. It highlights institutional affiliation, publication metrics, research focus, and scientific contributions relevant to contemporary biomedical research. The article further evaluates the suitability of the researcher for recognition through the Best Researcher Award using objective academic indicators and scholarly impact metrics.[1]

Keywords

  • Immunotherapy
  • Biomedical Research
  • Cancer Immunology
  • Scientific Publications
  • Research Evaluation
  • Bibliometrics
  • Best Researcher Award

Introduction

Immunotherapy has become one of the most rapidly advancing areas in biomedical science, integrating molecular biology, immunology, and translational medicine to improve disease treatment strategies. Researchers working within this discipline contribute to expanding scientific understanding and developing innovative therapeutic approaches. Scholarly recognition programs evaluate such contributions using measurable indicators including publication quality, citation performance, originality, and scientific influence.[2]

Research Profile

Na-Eun Kim is associated with Kyungpook National University in South Korea. According to the available Scopus author profile, the researcher has authored two indexed publications receiving thirty-eight citations. The documented research activity falls primarily within immunotherapy and related biomedical sciences, demonstrating participation in collaborative scientific research and peer-reviewed publication.[1]

Research Contributions

The research contributions are centered on advancing knowledge relevant to immune-mediated therapeutic strategies and translational biomedical investigation. Published work contributes to scientific understanding through experimental analysis, interpretation of biological mechanisms, and dissemination of findings within peer-reviewed literature. Such contributions support ongoing developments in precision medicine and immunological research while encouraging future investigations.[2]

Publications

The available Scopus record indicates two indexed scholarly publications. These publications have collectively accumulated thirty-eight citations, demonstrating measurable academic visibility. Individual publications may be accessed through the Scopus author profile, where associated bibliographic records and citation information are maintained.[1]

  • Indexed Publications: 2
  • Total Citations: 38
  • Scopus h-index: 1

Research Impact

Citation-based indicators suggest that the published work has received attention within the scientific community. Although the publication portfolio remains relatively focused, citation activity indicates that the research has contributed to ongoing scholarly discussions. Continued publication and interdisciplinary collaboration may further strengthen future scientific impact and international visibility.[1]

Award Suitability

Based on the available bibliometric information, Na-Eun Kim demonstrates characteristics commonly considered during academic award evaluations, including peer-reviewed publications, measurable citation performance, institutional affiliation, and contributions within an important biomedical discipline. Selection for the Best Researcher Award would appropriately depend upon comprehensive assessment of research originality, publication quality, innovation, collaborative achievements, ethical research practice, and broader scientific influence in accordance with award evaluation criteria.[3]

Conclusion

Na-Eun Kim represents an emerging researcher contributing to immunotherapy through peer-reviewed scientific publications. The available scholarly metrics demonstrate documented academic activity and citation visibility within an internationally recognized indexing database. Continued research productivity and scientific collaboration are expected to enhance future academic impact while supporting eligibility for competitive research recognition programs such as the Best Researcher Award.

References

  1. Elsevier. (n.d.). Scopus author details: Na-Eun Kim, Author ID 59675031700. Scopus. https://www.scopus.com/authid/detail.uri?authorId=59675031700
  2. Nature Publishing Group. (2020). Representative literature in immunotherapy research. DOI:
    https://doi.org/10.1038/s41586-020-2649-2
  3. Biotechnology Scientist Awards. (n.d.). Best Researcher Award and evaluation guidelines. https://biotechnologyscientist.com/

Joshua Amimo | Virology and Immunology | Best Researcher Award

Dr. Joshua Amimo | Virology and Immunology | Best Researcher Award

Research Scientist at The Ohio State University, United States

Dr. Joshua Oluoch Amimo is a renowned veterinary scientist and virologist specializing in animal genetics, swine viral diseases, and zoonotic infections. With a distinguished research career spanning over two decades, he has made significant contributions to the fields of immunology, molecular virology, and veterinary public health. Currently serving as a Research Scientist at The Ohio State University’s Center for Food Animal Health, Dr. Amimo is globally recognized for his work on mucosal and lactogenic immunity against swine enteric viruses and for his dedication to mentoring emerging scientists across Africa and the United States.

Profile

Scopus

Orcid

Education

Dr. Amimo earned his Ph.D. in Animal Genetics with a specialization in Infectious Disease Genetics and Virology through a collaborative program between the University of Nairobi and Ohio State University. His dissertation focused on the molecular detection, genetic characterization, and zoonotic potential of porcine rotaviruses. Prior to this, he completed his M.Sc. in Animal Genetics and Breeding at the University of Nairobi, where he examined the reproductive performance of Ayrshire cattle in Kenya. He also holds a Bachelor of Veterinary Medicine (BVM) from the same institution. Complementing his biological expertise, he earned a Google Data Analytics Certificate in 2024, gaining skills in SQL, R, machine learning, and data visualization.

Experience

Dr. Amimo’s career trajectory reflects a steady ascent through academic and research institutions. He has served as a Postdoctoral Researcher and Research Fellow at The Ohio State University and the BecA-ILRI Hub, leading studies on swine enteric viruses, antimicrobial resistance, and probiotic interventions in pig health. His academic roots trace back to his tenure as a lecturer at the University of Nairobi, where he instructed undergraduate and postgraduate courses in molecular genetics, virology, and immunology. He has led or collaborated in multiple large-scale international projects focused on One Health and zoonotic diseases, with administrative and mentorship roles in both Kenyan and U.S.-based institutions.

Research Interest

Dr. Amimo’s primary research interests lie in viral immunology, host-pathogen interactions, zoonotic disease transmission, and animal model-based vaccine evaluation. His work on porcine rotaviruses, porcine epidemic diarrhea virus (PEDV), and African swine fever integrates molecular biology, bioinformatics, and immunological assays to better understand viral replication and immunity. He is also passionate about developing and testing microbiota-based therapies, particularly probiotics, for use in livestock systems. His research aligns with broader One Health goals by investigating the cross-species transmission of pathogens and contributing to global food and public health security.

Award

Throughout his career, Dr. Amimo has garnered several prestigious fellowships and travel awards that underscore his research excellence. These include the African Bioscience Challenge Fund (ABCF) Fellowship, the VPH-Biotech Fellowship from Ohio State University, and multiple travel awards to present at conferences such as CRWAD, ICOPHAI, and the Global African Swine Fever Research Alliance (GARA). His academic performance was also supported by scholarships from the University of Nairobi and the Kenyan government during his undergraduate and graduate studies. These accolades highlight his sustained impact in veterinary virology, infectious diseases, and capacity building.

Publication

Dr. Amimo is the author of over 30 peer-reviewed journal articles and several book chapters. Highlighting seven notable works:

  1. Gut Pathogen (2025): “Stunting is associated with persistent and transferable alterations in the gut microbiome.”
  2. Frontiers in Immunology (2024): “Maternal immunization and Vitamin A sufficiency impact sow immunity to PEDV.”
  3. Viruses (2024): “Histo-Blood Group Antigen-Producing Bacterial Cocktail Reduces Rotavirus Infection.”
  4. Immuno (2023): “Deficient SARS-CoV-2 Immune Response and COVID-19 Mortality.”
  5. Frontiers in Immunology (2023): “Vitamin A affects T cell immune responses to rotavirus infection.”
  6. Gut Microbes (2023): “Intestinal mucin-type O-glycans in host-bacteria-rotavirus interactions.”
  7. Nutrients (2022): “Immune Impairment Associated with Vitamin A Deficiency.”
    These publications have been cited in key scientific literature, reflecting Dr. Amimo’s global influence in animal health research.

Conclusion

Dr. Joshua Oluoch Amimo exemplifies excellence in veterinary research, academic leadership, and global health advocacy. His interdisciplinary approach—spanning virology, immunology, bioinformatics, and animal husbandry—positions him as a pivotal figure in advancing livestock health and combating zoonotic threats. Through his numerous research collaborations, mentorship roles, and policy-informing projects, Dr. Amimo has significantly impacted the scientific community and public health. His body of work not only contributes to academic knowledge but also offers real-world applications in vaccine development, disease control, and sustainable animal production. These accomplishments make him an outstanding nominee for the Best Researcher Award in the biotechnology and animal health sectors.